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Abstract: Autophagy-related (Atg) gene-encoded proteins were originally described for their 
crucial role in macroautophagy, a catabolic pathway for cytoplasmic constituent degradation in 
lysosomes. Recently it has become clear that modules of this machinery can also be used to influence 
endo- and exocytosis. This mini review discusses how these alternative Atg functions support virus 
replication and viral antigen presentation on major histocompatibility (MHC) class I and II 
molecules. A better understanding of the modular use of the macroautophagy machinery might 
enable us to manipulate these alternative functions of Atg proteins during anti-viral therapies and 
to attenuate virus-induced immune pathologies. 
Keywords: Epstein Barr virus; Varizella Zoster virus; poliovirus; coxsackie B virus; MHC class I 
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1. Introduction 
Autophagy is a cellular degradation process that delivers cytoplasmic constituents to lysosomes 
for nutrient recycling [1]. It consists of at least three pathways, which either allow for substrate 
acquisition directly at the lysosomal or late endosomal membrane, as in the case of micro- and 
chaperone-mediated autophagy, or engulf parts of the cytoplasm in a double-membrane surrounded 
vesicle, named autophagosome, which then fuses with lysosomes. The latter pathway is called 
macroautophagy and last year’s Nobel laureate Yoshinori Ohsumi identified the first 15 genes that 
contribute to the molecular machinery of this pathway [2]. These autophagy-related (atg) genes, of 
which now more than 30 have been identified, fall into four functional groups [1]. The Unc-51 Like 
Autophagy Activating Kinase 1 (ULK1)/Atg13 complex integrates the nutritional status of the cell via 
inhibitory phosphorylation by the mammalian target of rapamycin (mTOR). It itself regulates the 
activity of a lipid phosphorylating complex, namely the vacuolar vrotein vorting (VPS) 34/Beclin-1 
phosphatidylinositol (PI) 3 kinase complex, by phosphorylation. The resulting PI3P marks 
membranes that then recruit the LC3 lipidation complex, which couples in a ubiquitin-like fashion 
Atg8 orthologues (LC3A, LC3B1, LC3B2, LC3C, GABA receptor-associated protein (GABARAP), 
GABARP-L1 and GABARAP-L2) to phosphatidylethanolamine in membranes that are elongated to 
become the outer and inner autophagosome membrane. The Atg8 orthologues most likely contribute 
to this elongation and recruit substrates into autophagosomes. Finally, the closed autophagosome 
fuses with lysosomes involving Plekstrin homology domain-containing protein (PLEKHM) 1, 
syntaxin 17 and the fusion machinery that is also in part used by late endosomes [3,4]. In the resulting 
autolysosomes, the inner autophagosomal membrane and its cargo are degraded and nutrients 
recycled by transport into the cytosol. 
These modules of the macroautophagy machinery (ULK1/Atg13 complex, VPS34/Beclin-1 
complex, LC3 lipidation complex and autophagosome fusion complex) are also used for other cell 
biological processes that require the modulation of intracellular membranes [5]. In this review, I will 
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mainly discuss regulation of endo- and exocytosis by Atgs. Phagosomes that endocytose toll-like 
receptor (TLR) agonists, immune complexes via Fc receptor binding and apoptotic cell debris via 
scavenger receptors like T-cell immunoglobulin mucin protein (TIM) 4 [6–10] recruit LC3 to the 
cytosolic side of their membrane. This requires the VPS34/Beclin-1 complex and the LC3 lipidation, 
but not the ULK1/Atg13 complex. In contrast to macroautophagy this LC3-associated phagocytosis 
(LAP) requires, however, the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
(NOX2)-dependent production of reactive oxygen species (ROS) at the phagosomal membrane 
[7,10,11]. Depending on the cell type, LAP leads to enhanced degradation, substrate maintenance or 
fusion with specialized endosomal compartments [8–10]. Atg proteins are in addition involved in 
non-conventional secretion. Several substrates that lack signal peptides for co-translational insertion 
into the ER benefit from Atgs for their secretion. These include acyl-CoA-binding protein (Acb1) and 
interleukin 1β (IL-1β) [12–16]. In contrast to LAP, the molecular requirements for this pathway are 
just beginning to be elucidated, but it seems that the ULK1/Atg13, the VPS34/Beclin-1 and the LC3 
lipidation complexes are involved in Atg-supported exocytosis [12–14]. In addition Golgi-associated 
proteins (GRASPs), like GRASP55, and the SNAP receptors (SNAREs) Sec22b, syntaxin 3 and 5, 
soluble NSF attachment protein (SNAP) 23 and SNAP29 seem to be required for secretion [13,14,16]. 
However, the exocytosed cargo might be contained within the autophagosome, in the space between 
the inner and outer autophagosomal membrane, or attached to the outer autophagosomal membrane 
[15,17,18]. Thus, Atg-supported exocytosis might be either a redirection of autophagosomes for 
fusion with the cell membrane rather than with lysosomes or an alternative use of LC3-conjugated 
membranes without autophagosome generation. In the following review, I will discuss how 
macroautophagy, LAP and Atg-supported exocytosis influence viral replication and viral antigen 
presentation on major histocompatibility complex (MHC) molecules. 
2. Autophagic Envelope Acquisition by Herpes Viruses 
Such redirected fusion with the plasma membrane and release of the inner autophagosomal 
membrane might be used by some herpes viruses [19] (Figure 1). Herpes viruses are enveloped large 
double-stranded DNA viruses that undergo two envelope acquisitions during lytic replication, 
allowing non-cytolytic release from infected cells [20]. The first envelope is generated by the budding 
of the herpes viral capsid, which is assembled in the nucleus of infected cells, through the inner 
nuclear membrane. This envelope is lost after fusion with the outer nuclear membrane and the capsid 
then acquires tegument proteins in the cytosol. Herpes viruses acquire their second envelope from 
ER and Golgi membranes and then travel surrounded by two membranes to the cell surface, where 
the outer membrane fuses with the cell membrane and the inner membrane becomes the final herpes 
virus envelope. Within the herpes virus family there are several members that seem to inhibit 
macroautophagy during lytic replication, often targeting Beclin-1 with their Bcl-2 homologues or 
herpes simplex virus (HSV) encoded infected cell protein (ICP) 34.5 [21,22]. These include the α-
herpes virus HSV and the γ-herpes virus Kaposi sarcoma-associated herpes virus (KSHV). 
Interestingly, within the same subfamilies of herpes viruses (α and γ), two other viruses, varicella 
zoster virus (VZV) and Epstein Barr virus (EBV), utilize LC3-coated membranes for their second 
envelopes [23,24]. EBV was found to accumulate LC3-conjugated membranes upon induction of lytic 
replication in both B and epithelial cells [23]. Inhibition of the LC3 lipidation complex reduced the 
production of infectious viral particles, while rapamycin inhibition of mTOR, and the consequent 
activating of the ULK1/Atg13 complex, stimulates virus production [23,25]. Upon inhibition of LC3 
lipidation, viral genomes accumulate in the cytosol, presumably lacking efficient second envelope 
acquisition [23]. Consistent with autophagic membranes contributing to the viral envelope, purified 
EBV particles contain lipidated LC3. Similarly, LC3-coupled membranes accumulate during VZV 
infection [26]. Inhibition of the VPS34/Beclin-1 complex with 3-methyladenine or the LC3 lipidation 
complex by Atg5 silencing compromises infectious virus production and viral glycoprotein (VZV gE) 
accumulation in cytoplasmic membranes. Furthermore, lipidated LC3 can also be found in purified 
VZV particles, and VZV gE partially colocalizes with LC3 in the cytoplasm [24]. These experiments 
suggest that viral glycoproteins get stabilized in LC3 coated membranes, which are then incorporated 
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into the envelopes of EBV and VZV. If these enveloped capsids, however, then use the machinery for 
Atg-supported exocytosis that I have described above, this needs further investigation. Nevertheless, 
it is quite likely that the respective herpes viruses hijack such existing pathways of exocytosis that 
utilize parts of the macroautophagy machinery. 
 
Figure 1. Viral exocytosis with autophagic membranes. Viruses, like some herpes and some 
picornaviruses, seem to sample LC3B coated membranes for their envelope, which are enriched in 
phosphatidylserine for scavenger receptor uptake. 
3. Atg Assisted Exocytosis of Picornaviruses 
While herpes viruses select membranes from Golgi and ER, which are considered primary sites 
of autophagosome generation [27,28], and then travel in phenotypically autophagosome-like 
structures to the cell membrane [29,30], it is far less obvious how non-enveloped RNA viruses, such 
as the picornaviruses poliovirus, coxsackie B virus and rhinoviruses, benefit from autophagic 
membranes. Nevertheless, the first study that actually observed double-membrane-surrounded 
vesicle accumulation upon viral infection was performed with poliovirus [31]. Indeed, these 
accumulating membranes need the LC3 lipidation complex for their formation [32]. While some 
flaviviruses, like hepatitis C virus and chikungunya virus, use enlarged membrane compartments, 
which in part depend on the autophagic machinery for their RNA replication [33–35] and Norovirus 
RNA replication complexes are restricted by the LC3 conjugation complex [36], picornaviruses seem 
to use autophagic membranes for non-cytolytic spreading of their infection [37]. Indeed, poliovirus 
release was reported to require autophagosome maturation with acidification [38] and be inhibited 
by microtubule transport [39]. However, such viral exocytosis from double-membrane-surrounded 
cytoplasmic vesicles would result in viral particles surrounded by the inner autophagosomal 
membrane and picornaviruses are considered non-enveloped. In paradigm-shifting studies, it was, 
however, discovered that picornaviruses can exit cells in a non-cytolytic fashion as packages of 
multiple viral particles, surrounded by LC3-conjugated membranes [40,41] (Figure 1). Indeed, mature 
coxsackie B viruses were found in extracellular microvesicles containing lipidated LC3 [40]. This non-
cytolytic release of poliovirus was dependent on the VPS34/Beclin-1 and LC3 lipidation complexes 
[41]. It resulted in extracellular microvesicles with around 20 viral particles surrounded by single 
LC3-coated membranes [41]. The benefit for non-enveloped picornaviruses to spread in extracellular 
microvesicles could be the non-cytolytic release, thereby maintaining virus production without host 
cell death for prolonged periods of time, and protection from host immunity, such as anti-viral 
antibodies, in the extracellular space. However, why is the sampling of autophagic membranes for 
these virus packages particularly attractive? One reason for this could be the particular lipid 
composition of autophagic membranes. In poliovirus-infected cells it was found that the membranes 
of the released viral particle-containing microvesicles are enriched in phosphatidylserine (PS) [41] 
(Figure 1). PS is also exposed on apoptotic bodies after programmed cell death and recognized by 
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scavenger receptors on phagocytes for clearance of this cellular debris [42]. Indeed, blocking of two 
of these receptors, TIM and tyrosine-protein kinase receptor UFO (AXL), or of PS itself blocks efficient 
infection with picornaviruses [41,43]. Thus, picornaviruses like polio-, coxsackie B- and rhinoviruses, 
recruit LC3-coated PS-rich membranes for their non-cytolytic release as packages of viral particles in 
order to facilitate infection of scavenger receptor-expressing phagocytes. After uptake, these PS-
containing membranes will be degraded followed by infection via the virus-specific receptors. 
However, as with herpes viruses, not all picornaviruses seem to use autophagic membranes in this 
fashion, because it was recently reported that Atg-independent budding into multivesicular bodies 
allows hepatitis A virus to acquire membranes for non-cytolytic release [44]. Therefore, as with 
herpes viruses, the future characterization of the molecular interactions of picornavirus proteins with 
the macroautophagy machinery might shed light on why some viruses exit cells with autophagic 
membranes and others do not. 
4. Exo- and Endocytosis with Atg Modules for MHC Class I Antigen Presentation 
A similar exocytosis of autophagic membranes might give rise to exosomes and indeed LC3 has 
been found in exosome preparations [45]. These vesicles might be superior antigen formulations for 
cross-presentation on MHC class I molecules to cytotoxic CD8+ T cells [46]. Indeed, compromising 
the VPS34/Beclin-1 or the LC3 lipidation complex inhibits the antigen transfer from tumor- and virus-
infected cells to dendritic cells for efficient MHC class I presentation [47,48]. The generation and 
loading of these antigen-containing extracellular microvesicles can be enhanced by lysosome and 
proteasome inhibition, and the resulting vesicles are called defective ribosomal products containing 
autophagosome-rich blebs (DRibbles) [49]. Lysosome inhibition seems to promote their secretion and 
proteasome inhibition allows for their more efficient loading with defective ribosomal products, 
which are considered to be superior antigens for MHC class I loading (Figure 2). Such DRibble 
preparations have been successfully used for vaccination [49]. Thus, Atg-supported exocytosis allows 
also for antigen transfer to dendritic cells and their cross-presentation of such antigens on MHC class 
I molecules to cytotoxic CD8+ T cells. 
This beneficial role of the macroautophagy machinery for cross-presentation is counterbalanced 
by its role in restricting MHC class I and MHC class I-like antigen presentation on the cell surface of 
antigen-presenting cells (APCs) by endocytosis [50,51]. Indeed, the net outcome of deficiency in Atg 
components of the LC3 lipidation complex in myeloid or dendritic cells is an elevated, often CD8+ T 
cell-mediated adaptive immune control or immunopathology [52,53]. Furthermore, deficiency of the 
LC3 lipidation complex in intestinal epithelium improves CD8+ T cell mediated immune surveillance 
of colorectal cancer development [54]. In part, this enhanced CD8+ T cell response to professional and 
other MHC class I APCs is due to the fact that antigen-presenting MHC class I molecules are 
stabilized on the cell surface of LC3 lipidation deficient cells [50]. This accumulation is due to 
decreased internalization that results from a poor recruitment of the adaptor-associated kinase 1 
(AAK1) to MHC class I molecules in the absence of LC3 lipidation, and AAK1 facilitates MHC class 
I endocytosis for degradation (Figure 2). This results in increased priming of influenza A virus-
specific CD8+ T cells and decreased infection associated viral titers and pathology in the absence of 
LC3 lipidation in dendritic cells. Similar to this regulation of classical MHC class I molecule 
endocytosis, the LC3 lipidation machinery also supports internalization of the non-classical MHC 
class I-like molecule, CD1d [51]. This leads to enhanced glycolipid presentation on CD1d to NKT cells 
and improved NKT cell-mediated immune control of the Sphingomonas paucimobilis infection. 
Therefore, lipidated LC3 might recruit parts of the internalization machinery for classical MHC class 
I and CD1d to these molecules on the cell membrane, which facilitates their internalization, but 
restricts CD8+ T and NKT cell responses, respectively. 
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Figure 2. Atg8 orthologues regulate antigen presentation on MHC class I and II molecules. LC3B 
coated autophagosomes and phagosomes deliver intracellular and extracellular antigens for MHC 
class II presentation, respectively. LC3B positive DRibbles get processed for antigen presentation on 
MHC class I molecules and MHC class I molecules get internalized in an LC3B and adaptor associated 
kinase 1 (AAK1) dependent fashion. 
5. Autophagy and LAP for MHC Class II Antigen Presentation 
In a mechanism that might be related to the Atg-supported internalization of MHC class I 
molecules, the VPS34/Beclin-1 and LC3 lipidation complexes also regulate phagocytosis. This 
pathway is called LAP [8]. LAP was found to support MHC class II-restricted presentation of 
phagocytosed antigen to CD4+ helper T cells [10,55,56] and to restrict inflammation at the intestinal 
mucosa [57,58]. TLR2-engaging Candida albicans extract was found to be maintained for prolonged 
periods of time in human macrophages and dendritic cells before being presented to specific CD4+ T 
cell clones [10]. LC3B was found to be recruited to these Candida-containing phagosomes in a NOX2 
function-dependent fashion. This LC3B coat was maintained on phagosomes for hours and 
deconjugated before fusion with lysosomes. In contrast, the C-type lectin receptor Dectin-1 
phagocytoses also cargo by LAP in mouse macrophages [55]. This results in rapid lysosomal fusion 
and presentation on MHC class II molecules, presumably due to more efficient transport to lysosomes 
along microtubules [59] and/or more efficient fusion [3]. These studies suggest that the 
macroautophagy machinery without the ULK1/Atg13 complex can regulate endocytosis, improving 
antigen presentation of extracellular antigens on MHC class II molecules to CD4+ T cells (Figure 2). 
In addition to this extracellular antigen processing via Atgs, intracellular antigens can also be 
presented via macroautophagy on MHC class II molecules [60] (Figure 2). Among these are also the 
macroautophagy proteins LC3B, GABARAP and GABARAP-L2 [61,62]. This intracellular self-
antigen presentation seems to contribute to positive and negative CD4+ T cell selection in the thymus 
[63–65]. Furthermore, some viral proteins are presented on MHC class II molecules after 
macroautophagy [66–68], and mycobacterial pathogens have developed strategies to inhibit this 
pathway [69]. However, most impressively, intracellular antigens that are coupled to the N-terminus 
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to LC3B get more efficiently presented on MHC class II molecules [64,70–74]. This enhanced 
presentation extends to influenza, melanoma, SIV/HIV and self-antigens, and can be achieved in 
dendritic, B, epithelial and tumor cells. Depending on the cell type and its capacity to present 
intracellular antigens on MHC class II molecules, CD4+ T cell recognition can be boosted up to 20-
fold both in vitro and in vivo [70,74]. Thus, macroautophagy can transport intracellular antigens to 
MHC class II loading compartments for antigen processing and presentation to CD4+ T cells. This 
indicates that both extracellular and intracellular antigens benefit from the Atg core machinery of the 
VPS34/Beclin-1 and LC3 lipidation complexes for presentation on MHC class II molecules. 
6. Conclusions and Outlook 
The above-described studies reveal a modular composition of the macroautophagy machinery, 
in which just some of these modules can be used for endocytosis and exocytosis, in addition to 
cytoplasmic constituent degradation in lysosomes, which is the classical function of macroautophagy. 
It will be important to unravel how these modules are differentially recruited for these different tasks 
and how the resulting pathways might be individually therapeutically regulated. Viruses can show 
us the way to understand the underlying biological processes better, because they have most likely 
not developed separate pathways in order to use Atgs for their non-cytolytic release from infected 
cells, but hijack existing mechanisms of non-conventional secretion. Furthermore, it will be 
interesting to explore the possibility that LAP or Atg-supported endocytosis in general is also utilized 
by viruses during their entry. 
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